Trials / Conditions / NSCLC Stage IV Without EGFR/ALK Mutation

NSCLC Stage IV Without EGFR/ALK Mutation

5 registered clinical trials studyying NSCLC Stage IV Without EGFR/ALK Mutation — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer NCT06951399	Rabin Medical Center	Phase 2
Recruiting	Study on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the A NCT06953843	Xinqiao Hospital of Chongqing	Phase 2
Recruiting	A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the T NCT06947694	Xinqiao Hospital of Chongqing	Phase 2
Active Not Recruiting	Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Ca NCT03808662	Memorial Sloan Kettering Cancer Center	Phase 2
Unknown	Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer NCT06207292	Radiotherapy Oncology Centre "Santa Maria" Hospital	N/A